论文部分内容阅读
目的:研究两种质子泵抑制剂治疗内镜下止血后再出血的胃十二指肠溃疡临床疗效及不良反应。方法:选取我院2013年9月至2015年9月期间入院接受治疗的胃十二指肠溃疡患者120例,经分组后,分为了实验组和对照组各60例,其中对照组采取奥美拉唑静滴治疗,实验组则采取雷贝拉唑口服治疗,对比两组患者的治疗结果。结果:两组患者经一个疗程治疗后,进行胃镜观察后,实验组患者治疗结果有效率高于对照组,且再出血率低于对照组,经比较,P<0.05,表明本次试验结果,有显著差异。结论:在临床中,为更好的保证患者的治疗效果,可口服使用贝雷拉唑以及奥美拉唑急性静脉滴注,可有效的改善患者在治疗中的安全性,同时为患者的治疗安全性,提供了执行保障。对于患者在相应的治疗安全准则保护上,可进行推广使用。
Objective: To study the clinical efficacy and adverse reactions of two proton pump inhibitors in the treatment of gastroduodenal ulcer after endoscopic hemostasis. Methods: A total of 120 patients with gastroduodenal ulcer admitted to our hospital from September 2013 to September 2015 were divided into experimental and control groups, 60 cases in each group. Oxygen Lazole intravenous infusion of treatment, the experimental group took oral rabeprazole treatment, the treatment of patients in two groups compared the results. Results: Two groups of patients after a course of treatment, gastroscopy, the experimental group of patients treated with effective rate was higher than the control group, and the rate of rebleeding was lower than the control group, by comparison, P <0.05, indicating that the results of this test, There are significant differences. Conclusion: In clinical practice, oral administration of bererazole and omeprazole can effectively improve the safety of patients during treatment in order to better ensure the therapeutic effect of the patients. At the same time, Security, provided the implementation of security. For patients in the corresponding treatment guidelines for the protection of security, can be promoted.